Please assess the completion status of the following clinical trial:

Trial Title: Pulmonary Embolism and PCT. PE-PCT Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age over 18 years~* CT diagnosis of pulmonary embolism~* Temperature\> 37.8 ° C~* About affiliated to the social security~* Prior agreement with the patient signing a consent~Exclusion Criteria:~* Pregnant Woman~* Refusal of the patient~* Pulmonary Neoplasia~* Antibiotic ongoing for more than 24 hours at the time of diagnosis of pulmonary embolism~* Cardiogenic shock (hypotension with mean arterial pressure less than 65 bpm)~* Suspicion of infection other than lung associated (associated urinary tract infection, prostatitis, ENT infection, sinusitis ...)~* Patient under guardianship~* Patients unable to give consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- clinical group (Type: EXPERIMENTAL): In the first group of patients, the use of antibiotics will be guided by clinical (clinical group).
- PCT group (Type: OTHER): In the second group, the use of antibiotics will be guided by the algorithm (PCT group).

Based on this trial design, predict the completion outcome and termination type (if applicable).